SES · H02.SI
Haw Par Corporation Limited
SGD 12.96+SGD 0.08 (+0.62%)
Haw Par Corporation Limited’s quoted price sits in the lower half of its reported 52-week range, 29.06% below the high.
Loading market information…
SES · 1H3.SI · SGD
Stock price, earnings
Quote as of Oct 29, 2026, 08:58 AM UTC. Cached market data; not a live quote.
One-year closing-price history · SGD. Historical prices are not a forecast.
Clearbridge Health Limited’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Clearbridge Health Limited’s next earnings report is currently expected on Feb 26, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Clearbridge Health Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in 2010 and headquartered in Singapore, Clearbridge Health Limited operates as an investment holding company, delivering diverse healthcare solutions globally, including in Singapore, the Philippines, Hong Kong, and Malaysia. The firm's activities are organized into three key divisions: Strategic Investments, Healthcare Systems, and Medical Clinics/Centres. Its extensive range of services encompasses advanced imaging diagnostics, such as general X-ray, CT scans (including dental cone beam), mammography, MRI, and ultrasound. Furthermore, Clearbridge offers general wellness screenings for conditions like diabetes, high blood pressure, and elevated cholesterol, alongside vaccination programs. Specialized care includes renal treatment, clinical services, aesthetic procedures, and dental and orthodontic services. Beyond patient care, the company provides consultancy to healthcare organizations and is involved in the wholesale supply of medicinal and pharmaceutical products.
Latest available per-share figures in SGD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:01 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
SGD 12.96+SGD 0.08 (+0.62%)
Haw Par Corporation Limited’s quoted price sits in the lower half of its reported 52-week range, 29.06% below the high.
SGD 0.82+SGD 0.01 (+0.61%)
Raffles Medical Group Ltd’s quoted price sits in the lower half of its reported 52-week range, 24.07% below the high.
SGD 0.05+SGD 0.00 (+2.13%)
Thomson Medical Group Limited’s quoted price sits in the lower half of its reported 52-week range, 28.36% below the high.
SGD 0.74-SGD 0.01 (-0.68%)
Riverstone Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 25.38% below the high.
$9.58-$0.70 (-6.81%)
Adlai Nortye Ltd.’s quoted price sits in the upper half of its reported 52-week range, 44.29% below the high.
$0.46-$0.02 (-3.16%)
UltraGreen.ai Limited’s quoted price sits in the lower half of its reported 52-week range, 75.27% below the high.
SGD 0.51+SGD 0.01 (+2.0%)
iX Biopharma Ltd.’s quoted price sits in the upper half of its reported 52-week range, 18.4% below the high.
SGD 0.49SGD 0.00 (0.0%)
Q & M Dental Group (Singapore) Limited’s quoted price sits in the lower half of its reported 52-week range, 22.83% below the high.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
